Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
NCT Number: NCT03071237
Infrapyloric artery(IPA) is of great importance for gastric cancer patients. According to previous study, the origin of IPA varies greatly among different studies. This trial aims to tell the distribution of IPA origin in Chinese patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Beijing, Beijing Municipality, 100142, China
Infrapyloric artery(IPA) is of great importance for gastric cancer patients. In early gastric cancer patients, the pylorus-preserving gastrectomy requires the preserving of IPA. In advanced gastric cancer patients, the subgroup of No. 6 lymph node might be associated with IPA. In Japanese Gastric Cancer Association(JGCA) gastric cancer classification guidelines, the No. 6 lymph nodes is defined as lymph nodes along the first branch and proximal part of the right gastroepiploic artery(RGEA) down to the confluence of the right gastroepiploic vein and the anterior superior pancreatoduodenal vein. However,if IPA origins from the gastroduodenal artery(GDA) or anterior superior pancreatoduodenal artery(ASPDA), the lymph nodes along the IPA can not be grouped into the No. 6 lymph nodes. Thus, a new definition of No. 6 lymph nodes is needed on the basis of the origin of IPA.
Previous studies about IPA origin are few and the origin of IPA varies greatly among different studies.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients with gastric cancer that needs receiving total or distal gastrectomy. During the surgery, IPA needs to be exposed and transected.
Other names: surgery
Time frame: Immediately after surgery
The percentage of IPA origin from GDA, ASPDA and RGEA.
Time frame: Immediately after the reconstruction of CT scan.
The rate of identification of IPA origin by reconstruction of CT scan.
Peking University
Other
The Origin of Infrapyloric Artery: an Observational Trial
Acronym: IPA-Origin
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03013010
Adenocarcinoma, Carcinoma
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06563063
Digestive System Diseases, Digestive System Neoplasms
Seoul, South Korea
View Trial DetailsNCT05714878
Digestive System Diseases, Digestive System Neoplasms
Beijing, China
View Trial DetailsNCT03549494
Digestive System Disease, Digestive System Diseases
Havana, La Habana, Cuba
View Trial Details